Verona Pharma PLC (NAS:VRNA)
$ 30.01 -0.16 (-0.53%) Market Cap: 2.44 Bil Enterprise Value: 2.17 Bil PE Ratio: 0 PB Ratio: 14.42 GF Score: 29/100

Q4 2019 Verona Pharma PLC Earnings Call Transcript

Feb 27, 2020 / 02:00PM GMT
Release Date Price: $6.23 (-7.57%)
Operator

Welcome to Verona Pharma Full Year 2019 Financial Results and Operating Highlights Conference Call. (Operator Instructions)

Before we begin, I would like to remind you that during today's call, statements about the Company's future expectations, plans and prospects constitutes forward-looking statements. These forward-looking statements are based on management's current expectations. These statements are neither promises nor guarantees, and involve known and unknown risks, uncertainties, and other important factors that may cause our actual results, performance or achievements to be materially different from our expectations expressed or implied by the forward-looking statements. Any such forward-looking statements represent management's estimate as of the date of this conference call. While the company may elect to update such forward-looking statements at some point in the future, it disclaims any obligations to do so even if subsequent events cause its views to change. As a reminder, this call is being recorded.

I would now like to turn the call over to Dr. David Zaccardelli, Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot